Brain chemical dopamine linked to sleep apnea risk in new study
NCT ID NCT05890911
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times
Summary
This study looks at whether dopamine levels and certain genes affect the risk and severity of sleep breathing disorders like sleep apnea. Researchers will monitor 100 adults overnight and take blood samples to measure dopamine and check for genetic variations. The goal is to better understand the connection, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wroclaw Medical Uniwesity
Wroclaw, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could removing tonsils supercharge a sleep apnea implant?
- Pregnancy sleep problems may harm blood vessels
- Could oxygen or a common drug fix Opioid-Linked sleep apnea?
- Personalized sleep apnea treatment on the horizon?
- Sleep apnea amino acid study pulled before it started
- New study tracks sleep quality at home during first weeks of CPAP therapy